Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Apr 20 2022

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-apr-20-2022-7

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 20-Apr-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases